(C) Reuters. FILE PHOTO: A Walgreens store is seen in Chicago, Illinois, U.S. February 11, 2021. REUTERS/Eileen T. Meslar
(Reuters) – Walgreens Boots Alliance (NASDAQ:WBA) Inc reported a 68% surge in fourth-quarter profit on Thursday due to higher sales at its pharmacy stores in the United States and the United Kingdom, as COVID-19 restrictions eased in the quarter.
Walgreens, one of the largest U.S. pharmacies, has also been registering higher sales from administering COVID-19 vaccines and booster shots as Delta variant cases surged during the quarter.
Shares of the company were up 2.4% before the bell.
As of Aug. 31, Walgreens had administered more than 40 million COVID-19 vaccines, of the total 370.2 million shots administered in the United States.
Same-store sales at its U.S. pharmacies rose 8.8% in the fourth quarter as it filled 313 million prescriptions.
Net income attributable to the company was $627 million, or 72 cents per share, for the quarter ended Aug. 31, compared with a profit of $373 million, or 43 cents per share, a year earlier.
Revenue rose to $34.26 billion from $30.37 billion.
Walgreens profit surges 68% on strong pharmacy, retail sales
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.